Symbio Natural Products Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
- Paid Up Capital ₹ 0.18 M
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 80.92%
- Ebitda 85.64%
- Net Worth -4.55%
- Total Assets -2.28%
About Symbio Natural Products
Symbio Natural Products Private Limited (SNPPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 November 2017 (Seven years and three months 21 days old ). Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 0.18 M, as per Ministry of Corporate Affairs (MCA) records.
Abhijit Kale, Akash Puranik, and Salim Shaikh serve as directors at the Company.
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999TN2017PTC119375
- Company No.
119375
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Nov 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Symbio Natural Products?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhijit Kale  | Director | 03-Nov-2017 | Current |
| Akash Puranik | Director | 03-Nov-2017 | Current |
| Salim Shaikh | Director | 03-Nov-2017 | Current |
Financial Performance of Symbio Natural Products.
Symbio Natural Products Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 80.92% increase in profit. The company's net worth dipped by a decrease of 4.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Symbio Natural Products?
In 2022, Symbio Natural Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Symbio Generrics India Private LimitedAkash Puranik and Salim Shaikh are mutual person
Blumen Biovitals Healthkare Private LimitedSalim Shaikh is a mutual person
Vpl Chemicals Private LimitedAkash Puranik and Salim Shaikh are mutual person
Sequent Penems Private LimitedAkash Puranik and Salim Shaikh are mutual person
Copernicium Pharmaceuticals Private LimitedAkash Puranik and Salim Shaikh are mutual person
- Strider Lifesciences Private Limited
Salim Shaikh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Symbio Natural Products?
Unlock and access historical data on people associated with Symbio Natural Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Symbio Natural Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symbio Natural Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.